UniProtKB/Swiss-Prot Q15319 : Variant p.Glu232Lys
POU domain, class 4, transcription factor 3
Gene: POU4F3
Variant information
Variant position: 232 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: USThe variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change: From Glutamate (E) to Lysine (K) at position 232 (E232K, p.Glu232Lys).Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: Change from medium size and acidic (E) to large size and basic (K)The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: 1The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description: In DFNA15; unknown pathological significance.Any additional useful information about the variant.
Sequence information
Variant position: 232 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 338 The length of the canonical sequence.
Location on the sequence:
LANLKIPGVGSLSQSTICRF
E SLTLSHNNMIALKPVLQAWL
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human LANLKIPGVGSLSQSTICRFE SLTLSHNNMIALKPVLQAWL
Mouse LANLKIPGVGSLSQSTICRFE SLTLSHNNMIALKPVLQAWL
Rat LANLKIPGVGSLSQSTICRFE SLTLSHNNMIALKPVLQAWL
Zebrafish LANLKIPGVGSLSQSTICRFE SLTLSHNNMIALKPVLQAWL
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 338
POU domain, class 4, transcription factor 3
Domain
179 – 256
POU-specific
Literature citations
Targeted massive parallel sequencing: the effective detection of novel causative mutations associated with hearing loss in small families.
Baek J.I.; Oh S.K.; Kim D.B.; Choi S.Y.; Kim U.K.; Lee K.Y.; Lee S.H.;
Orphanet J. Rare Dis. 7:60-60(2012)
Cited for: VARIANT DFNA15 LYS-232;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.